Stock listing

Havn Life Sciences Inc

Selected listing: A3DR7N · LSX · EUR · DE

Havn Life Sciences Inc (LS Exchange: A3DR7N), Health Technology. Latest release Nov 22, 2023: HAVN LIFE SCIENCES : Announces Cease Trade Order.

A3DR7N:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A3DR7N
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

About Havn Life Sciences Inc

The company focuses on the development of psychedelic compounds and their applications in mental health treatments. Havn Life aims to advance research and innovation in the field of psychedelics to improve patient outcomes.

Latest news from Havn Life Sciences Inc

HAVN LIFE SCIENCES : Announces Cease Trade Order

November 22, 2023

HAVN LIFE SCIENCES : Announces Filing of Annual Report by November 10, 2023

October 15, 2023

HAVN LIFE SCIENCES : PROVIDES BI-WEEKLY MCTO STATUS UPDATE

October 13, 2023

HAVN Life Sciences : ANNOUNCES ANTICIPATED LATE FILING OF FINANCIAL STATEMENTS AND APPLICATION FOR MANAGEMENT CEASE TRADE ORDER

August 31, 2023

HAVN Life Sciences : ANNOUNCES CHANGE OF AUDITOR

July 26, 2023

All Havn Life Sciences Inc news →

Research Havn Life Sciences Inc

Havn Life Sciences Inc company profile

View the public company page for Havn Life Sciences Inc on 6ix.

Havn Life Sciences Inc news

Read company news and market updates connected to Havn Life Sciences Inc.

Havn Life Sciences Inc investor events

Find investor webinars, events, and replay context for Havn Life Sciences Inc.